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Regulation of the retroviral protein production largely
depends upon regulation of the alternative splicing of the
viral transcript. The Tat protein is required for transcrip-
tion of full-length HIV-1 RNA and therefore is essential for
virus multiplication. However, as the Tat protein has
apoptotic properties, virus HIV-1 limits tat mRNA produc-
tion through a strong down regulation of splicing at site
A3, an HIV-1 splicing site specifically dedicated to tat
mRNA production. Splicing at this site is modulated by a
complex array of silencer and enhancer elements con-
tained in a long stem-loop structure SLS3, which is located
downstream from site A3. Earlier studies have shown that
the main inhibitory element ESS2 is a strong hnRNP A1
entry site, allowing further hnRNP A1 binding on the
SLS3 region and leading to limitation of the U2AF splicing
factor association. The SR proteins SC35 and SRp40 bind-
ing sites overlap ESS2, and their association strongly acti-
vates splicing at site A3. We found that two other SR
proteins, ASF/SF2 and 9G8 also activate site A3 utiliza-
tion. However, our experimental study revealed different
pattern of interaction of these proteins with SLS3, as com-
pared to SC35 and SRp40. They have short juxtaposed
binding sites that overlap a C-to-U mutation position
5396 which was shown to induce a strong decrease of tat1
mRNA production in cellulo. The analysis by mass spec-
trometry of the proteins bound on SLS3 with a C or a U
residue at position 5396 revealed the presence of the
inhibitory splicing protein DAZAP1. Its binding is
strongly reinforced by the C to U substitution. Based on
our present data, the activation properties of ASF/SF2 and
9G8 proteins on site A3 are based on their capability to
block DAZAP1 binding to SLS3. Taken together, the data
reveal that numerous nuclear factors of the infected cells
are involved in the complex regulation of HIV-1 RNA
splicing.
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